Autopsy report · NCT03537222

Quality of Life in Patients With Multiple Myeloma-validation Study

“Not enough participants and study funding”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 2 years 10 months before it stopped.
• 58 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Zurich University of Applied Sciences

Sponsor type

University, hospital or other

Conditions

Multiple Myeloma

Interventions

Myeloma Patient Outcome Scale (MyPOS)

Participants

58

Sites

3

Countries

Switzerland

Trials that died the same way

• Midodrine Use in Septic Shock
  “No funding for the study; not enough staff” (81% match in meaning)
• Study of EQU-001 for Uncontrolled Focal Onset Seizures
  “insufficient funding to complete the study” (80% match in meaning)
• Efficacy of Kerecis Omega 3 in Comparison to Clinical Standard Procedures
  “Lack of funding to support the study” (76% match in meaning)
• Phase I Nicotinic Agonist Treatment Trial for Autism
  “difficult to find participants and no funding” (75% match in meaning)
• Open Label of Thalidomide in Treatment of Women With Chronic Pelvic Pain Associated With Endometriosis
  “Difficulty finding eligible participants and lack of funding.” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.